Targeting estrogen to kill ER-positive and ER-negative breast cancer

被引:0
|
作者
Jordan, VC [1 ]
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
关键词
D O I
10.1186/bcr1053
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S4 / S4
页数:1
相关论文
共 50 条
  • [21] Developmental and therapeutic implications of molecular profiles of ER-positive and ER-negative breast cancers.
    Perou, CM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S3 - S3
  • [22] Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer
    Chimge, Nyam-Osor
    Ahmed-Alnassar, Sara
    Frenkel, Baruch
    CELL CYCLE, 2017, 16 (04) : 312 - 318
  • [23] Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial
    Wapnir, Irene L.
    Price, Karen N.
    Anderson, Stewart J.
    Robidoux, Andre
    Martin, Miguel
    Nortier, Johan W. R.
    Paterson, Alexander H. G.
    Rimawi, Mothaffar F.
    Lang, Istvan
    Manuel Baena-Canada, Jose
    Thurlimann, Beat
    Mamounas, Eleftherios P.
    Geyer, Charles E., Jr.
    Gelber, Shari
    Coates, Alan S.
    Gelber, Richard D.
    Rastogi, Priya
    Regan, Meredith M.
    Wolmark, Norman
    Aebi, Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (11) : 1073 - +
  • [24] Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system
    Xiao, Bin
    Hang, Jianfeng
    Lei, Ting
    He, Yongyin
    Kuang, Zhenzhan
    Wang, Li
    Chen, Lidan
    He, Jia
    Zhang, Weiyun
    Liao, Yang
    Sun, Zhaohui
    Li, Linhai
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (02) : 2111 - 2119
  • [25] Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system
    Bin Xiao
    Jianfeng Hang
    Ting Lei
    Yongyin He
    Zhenzhan Kuang
    Li Wang
    Lidan Chen
    Jia He
    Weiyun Zhang
    Yang Liao
    Zhaohui Sun
    Linhai Li
    Molecular Biology Reports, 2019, 46 : 2111 - 2119
  • [26] Radiation Therapy Use and Outcomes Among Older Women With ER-Positive and ER-Negative Stage I Breast Cancer
    Shen, Xinglei
    Anne, Pramila R.
    Keith, Scott W.
    Wojcieszynski, Andrzej
    Mishra, Mark V.
    Bar-Ad, Voichita
    Showalter, Timothy N.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (03): : 241 - 247
  • [27] Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer
    Witton, CJ
    Hawe, SJK
    Cooke, TG
    Bartlett, JMS
    HISTOPATHOLOGY, 2004, 45 (01) : 47 - 54
  • [28] Estrogen-independent effects of ER-α36 in ER-negative breast cancer
    Zhang, Jing
    Li, Guangliang
    Li, Zhongqi
    Yu, Xiongfei
    Zheng, Yi
    Jin, Ketao
    Wang, Haohao
    Gong, Yun
    Sun, Xiaoping
    Teng, Xiaodong
    Cao, Jiang
    Teng, Lisong
    STEROIDS, 2012, 77 (06) : 666 - 673
  • [29] Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer
    Mazumdar, Abhijit
    Tahaney, William M.
    Hill, Jamal L.
    Zhang, Yun
    Ramachandran, Sumankalai
    Kawedia, Jitesh
    Qian, Jing
    Contreras, Alejandro
    Savage, Michelle I.
    Vornik, Lana A.
    Sei, Shizuko
    Mohammed, Altaf
    Brown, Powel H.
    CANCER PREVENTION RESEARCH, 2022, 15 (12) : 791 - 802
  • [30] Targeting the mTOR pathway for the prevention of ER-negative breast cancer
    Mazumdar, Abhijit
    Zhang, Yun
    Hill, Jamal
    Brown, Powel
    CANCER RESEARCH, 2016, 76